DOREENA TRAN: Open Payments
NPI 1487147286 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 27 payments from 11 companies in 2025. Trend: 2023 $3,191 · 2024 $2,065 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $180 |
| Corcept Therapeutics | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $49 |
| Astellas Pharma US Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Renalytix AI, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Wegovy, Korlym, MOUNJARO, Veozah, JARDIANCE, Ozempic, Kerendia, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
